Form 8-K - Current report:
SEC Accession No. 0001564590-19-036090
Filing Date
2019-10-01
Accepted
2019-10-01 16:16:04
Documents
14
Period of Report
2019-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20191001.htm   iXBRL 8-K 37800
2 EX-99.1 hrtx-ex991_6.htm EX-99.1 10501
3 GRAPHIC gkec0fpplnvk000001.jpg GRAPHIC 23447
  Complete submission text file 0001564590-19-036090.txt   214805

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20191001.xsd EX-101.SCH 5969
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20191001_lab.xml EX-101.LAB 19485
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20191001_pre.xml EX-101.PRE 11634
11 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20191001_htm.xml XML 3568
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 191129297
SIC: 2834 Pharmaceutical Preparations